Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase

Add time:07/14/2019    Source:sciencedirect.com

Inhibition of Thymidine phosphorylase (TP) is continuously studied for the design and development of new drugs for the treatment of neoplastic diseases. As a part of our effort to identify TP inhibitors, we performed a structure-based virtual screening (SBVS) of our compound collection. Based on the insights gained from structures of virtual screening hits, a scaffold was designed using 1,3,4-oxadiazole as the basic structural feature and SAR studies were carried out for the optimization of this scaffold. Twenty-five novel bis-indole linked 1,3,4-oxadiazoles (7–31) were designed, synthesized and tested in vitro against E. coli TP (EcTP). Compound 7 emerged as potent TP inhibitor with an IC50 value of 3.50 ± 0.01 μM. Docking studies were carried out using GOLD software on thymidine phosphorylase from human (hTP) and E. coli (EcTP). Various hydrogen bonding, hydrophobic interactions, and π-π stacking were observed between designed molecules and the active site amino acid residues of the studied enzymes.

We also recommend Trading Suppliers and Manufacturers of thymidine 5'-4-nitrophenyl phosphate (cas 2304-08-7). Pls Click Website Link as below: cas 2304-08-7 suppliers

Prev:Synthesis and molecular docking study of piperazine derivatives as potent inhibitor of thymidine phosphorylase
Next:Syntheses and configurational assignments of the diastereomers of the 4-nitrophenyl esters of thymidine 3′-(N-phenyl phosphoramidate) and thymidine 5′-(N-phenyl phosphoramidate))